9 results

389 The evolving understanding of histology as an endpoint in ulcerative colitis
Shintaro Akiyama, Yusuke Miyatani, David T. Rubin
KMSID: 1516088582   Intest Res. 2024;22(4):389-396.   Published online 2024 March 13    DOI: http://dx.doi.org/10.5217/ir.2023.00120
      
397 What to do when traditional rescue therapies fail in acute severe ulcerative colitis
Christopher F. D. Li Wai Suen, Matthew C. Choy, Peter De Cruz
KMSID: 1516088587   Intest Res. 2024;22(4):397-413.   Published online 2024 May 16    DOI: http://dx.doi.org/10.5217/ir.2024.00003
      
414 Complex dichotomous links of nonalcoholic fatty liver disease and inflammatory bowel disease: exploring risks, mechanisms, and management modalities
Kanishk Aggarwal, Bhupinder Singh, Abhishek Goel, Durgesh Kumar Agrawal, Sourav Bansal, Sai Gautham Kanagala, Fnu Anamika, Aachal Gupta, Rohit Jain
KMSID: 1516088585   Intest Res. 2024;22(4):414-427.   Published online 2024 June 5    DOI: http://dx.doi.org/10.5217/ir.2024.00001
      
428 Ulcerative colitis-associated neoplasms often harbor poor prognostic histologic components with low detection by biopsy
Ryoya Sakakibara, Shinya Sugimoto, Kaoru Takabayashi, Hiroki Kiyohara, Yusuke Wakisaka, Yuta Kaieda, Miho Kawaida, Yusuke Yoshimatsu, Tomohisa Sujino, Naoki Hosoe, Motohiko Kato, Masayuki Shimoda, Yohei Mikami, Yasushi Iwao, Takanori Kanai
KMSID: 1516088596   Intest Res. 2024;22(4):428-438.   Published online 2024 May 7    DOI: http://dx.doi.org/10.5217/ir.2024.00006
      
439 Defining management strategies for acute severe ulcerative colitis using predictive models: a simulation-modeling study
Danny Con, Peter De Cruz
KMSID: 1516088586   Intest Res. 2024;22(4):439-452.   Published online 2024 May 7    DOI: http://dx.doi.org/10.5217/ir.2023.00175
      
453 Predictors of histologic remission in patients with biologic-naïve, moderate-to-severe ulcerative colitis treated with first-line biologic agents and small-molecule drugs: a single-center, retrospective cohort study
Kijae Jo, Kwang Woo Kim, Hyun Jung Lee, Jong Pil Im, Joo Sung Kim, Seong-Joon Koh
KMSID: 1516088600   Intest Res. 2024;22(4):453-463.   Published online 2024 May 22    DOI: http://dx.doi.org/10.5217/ir.2024.00044
      
464 Efficacy of serum leucine-rich alpha-2 glycoprotein in predicting findings of Crohn’s disease small bowel lesion in capsule endoscopy
Teppei Omori, Miki Koroku, Shun Murasugi, Ayumi Ito, Maria Yonezawa, Shinichi Nakamura, Katsutoshi Tokushige
KMSID: 1516088584   Intest Res. 2024;22(4):464-472.   Published online 2024 May 7    DOI: http://dx.doi.org/10.5217/ir.2023.00139
      
473 Early change in serum leucine-rich α-2-glycoprotein predicts clinical and endoscopic response in ulcerative colitis
Ryo Karashima, Shintaro Sagami, Yoko Yamana, Masa Maeda, Aya Hojo, Yusuke Miyatani, Masaru Nakano, Takahisa Matsuda, Toshifumi Hibi, Taku Kobayashi
KMSID: 1516088583   Intest Res. 2024;22(4):473-483.   Published online 2024 June 5    DOI: http://dx.doi.org/10.5217/ir.2023.00135
      
484 Perianal fistulizing lesions of Crohn’s disease are associated with long-term behavior and its transition: a Chinese cohort study
Wei Zhan, Xiaoyin Bai, Hong Yang, Jiaming Qian
KMSID: 1516088597   Intest Res. 2024;22(4):484-495.   Published online 2024 July 15    DOI: http://dx.doi.org/10.5217/ir.2024.00021
      
Articles from Intestinal Research are provided here courtesy of Korean Association for the Study of Intestinal Diseases